April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Cosmetic preservatives as therapeutic corneoscleral tissue cross-linking (XL) agents
Author Affiliations & Notes
  • Natasha Babar
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, NY
  • Jessica R Cohen
    Mechanical Engineering, Columbia University, New York, NY
  • Michael J Fernandez
    Mechanical Engineering, Columbia University, New York, NY
  • Anna Takaoka
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, NY
  • Xia Li
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, NY
  • Mi Jung Kim
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, NY
  • Kristin M Myers
    Mechanical Engineering, Columbia University, New York, NY
  • Stephen L Trokel
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, NY
  • David C Paik
    Ophthalmology, Columbia University College of Physicians and Surgeons, New York, NY
  • Footnotes
    Commercial Relationships Natasha Babar, None; Jessica Cohen, None; Michael Fernandez, None; Anna Takaoka, None; Xia Li, None; Mi Jung Kim, None; Kristin Myers, None; Stephen Trokel, US,8,466,203 (P); David Paik, US,8,466,203 (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4214. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Natasha Babar, Jessica R Cohen, Michael J Fernandez, Anna Takaoka, Xia Li, Mi Jung Kim, Kristin M Myers, Stephen L Trokel, David C Paik; Cosmetic preservatives as therapeutic corneoscleral tissue cross-linking (XL) agents. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4214.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

The growing clinical success of riboflavin photochemical corneal cross-linking (CXL) suggests that inducing mechanical tissue strength in vivo can be beneficial. Alternatively, tissue cross-linking (XL) can be induced by aliphatic β-nitroalcohols, which deliver formaldehyde via a base-catalyzed reverse Henry reaction. There are a number of related agents, known as “formaldehyde releasers” (FARs), that are in commercial use as preservatives in cosmetics and other personal care products. Thus, the present study was undertaken in order to screen such compounds for potential clinical utility.

 
Methods
 

A chemical registry was created from a literature review and included characteristics relevant to XL such as molecular weight, carcinogenicity/mutagenicity, toxicity, hydrophobicity, and commercial availability. From this registry, compounds were then selected for efficacy screening using an ex vivo rabbit corneal cross-linking simulation set up. XL solution was administered via a corneal reservoir for 30 min in 0.1M NaHCO3 at either pH 7.4 or 8.5. The epithelium was left intact and 0.5% proparacaine was applied prior to XL. The control contralateral eye was treated identically with vehicle. Effectiveness of XL was based on shifts in thermal denaturation temperature (Tm) as measured by differential scanning calorimetry (Perkin-Elmer DSC 6000). Favorable DSC results were validated using biomechanical inflation tests with digital image correlation (DIC) as previously described by Myers et al.

 
Results
 

Sixty-four FARs (regularly found in cosmetics) were identified from the literature. Three compounds have been tested thus far [diazolidinyl urea (DAU), imidazolidinyl urea, and 5-Ethyl-3,7-dioxa-1-azabicyclo [3.3.0] octane]. Of the three, DAU has showed effective XL at pH 8.5. Compared to the controls, the Tm using DAU was shifted 1.92°C ± 0.14°C (n=2). Mechanical inflation testing confirmed increased tissue stiffness in pressure ranges mimicking physiological pressures (1.875-45mmHg). Tissue creep was also diminished under the current loading protocol (Fig. 1).

 
Conclusions
 

DAU is a potentially useful corneal XL agent as indicated by thermal denaturation and biomechanical inflation testing. Continued screening of compounds from the compiled chemical registry should lead to identification of additional potent agents.

 
 
Net apical displacement response over time for control and DAU cross-linked cornea at pH 8.5.
 
Net apical displacement response over time for control and DAU cross-linked cornea at pH 8.5.
 
Keywords: 574 keratoconus • 484 cornea: stroma and keratocytes • 519 extracellular matrix  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×